Career

Robert Bard Has Been Appointed as a Chair of Clinical Diagnostics at MBCGA

Robert Bard/LinkedIn

Jun 11, 2025, 13:48

Robert Bard Has Been Appointed as a Chair of Clinical Diagnostics at MBCGA

Cheri Ambrose, Founder of Male Breast Cancer Global Alliance (MBCGA), shared a post on LinkedIn:

“Robert Bard, MD Appointed Chair of Clinical Diagnostics at MBCGA

MEDICAL DIAGNOSTIC TRAILBLAZER IS THE NEXT MUSCLE IN MALE BREAST CANCER ADVOCACY

5-24-2025 / New York, NY — In a groundbreaking move that signals a powerful step forward in the fight against male breast cancer, the Male Breast Cancer Global Alliance (MBCGA) has announced the appointment of Dr. Robert Bard as Committee Chair of Clinical Diagnostics.

A visionary in medical imaging and an internationally recognized advocate for integrative cancer care, Dr. Bard brings decades of experience and innovation to a role designed to unify health professionals and elevate awareness around this often-overlooked disease. Dr. Bard’s new role is not merely ceremonial—it marks the official launch of a clinical diagnostics branch within MBCGA.

This division aims to centralize diagnostic expertise, standardize early detection methods, and serve as an educational hub for medical professionals worldwide. For MBCGA co-founder Cheri Ambrose, the appointment represents “the highest task” – entrusting a leader who can connect radiologists, oncologists, and integrative medicine experts in a cause that has lacked unified attention for too long.”

Robert Bard

Ginny Mason, Executive Director of the Inflammatory Breast Cancer Research Foundation, shared this post on LinkedIn, adding:

“So many people don’t think about men being at risk for breast cancer. It can be even harder to get men to follow-up symptoms with a mammogram. Can’t blame them for not wanting to enter those ‘Pepto-Bismol’ pink units, don a pink gown and sit in a waiting room filled with women. I’m not comfortable there either!! We can do better….and NEED to!”

Read Full Article.

Cheri Ambrose announced the appointment of Dr. Robert Bard as Chair of Clinical Diagnostics at MBCGA, marking the launch of a new division focused on standardizing early detection and expanding education for male breast cancer care.

Ginny Mason echoed the need for better inclusivity and awareness, highlighting ongoing barriers faced by male patients in seeking screening and care.

Read OncoDaily’s Special Article: “Male Breast Cancer: What patients should know about”

Robert Bard Has Been Appointed as a Chair of Clinical Diagnostics at MBCGA